Companies → AUDIFARMA S A
Save to list
Remove

AUDIFARMA S A

Colombia, Risaralda, Pereira
Description
by AI
The company was born in Pereira City in 1993; it's part of two important companies at Colombian level: Uribe Angel Group and Conconcreto Group. We are focused on the commercialization and distribution of generic medicines at the third party payer pre-paid regime; we are also focused on our business unit OTC Consumer (medicines without prescription and personal care items). We work with high-quality and widely recognized laboratories such as: Meditech, Ciba, Chiesi, Valeant, BSN Medical-CliniMed and Laboratories Astra Zeneca. During more than 20 years, Audifarma has become one of the most important generic medicines distribuitors at the national level. We have achieved a profitable trading and a great financial soundness, being the best support for our commercial activities. We have had a challenging and quick growth and constantly growing up at storage, transportation and dispatching processes.
Address:

CALLE 105 14 140 BARRIO BELMONTE ZONA INDUSTRIAL DE OCCIDENTE PEREIRA

Risaralda Colombia

Revenue
Company is likely to buy
Company is likely to sell
Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.